What Is the Role for TAVI in Failing Surgical Aortic Valves? A Review on Valve-in-Valve Interventions

Document Type

Article

Publication Date

8-1-2025

Publication Title

Catheterization and cardiovascular interventions

Keywords

Humans, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement, Bioprosthesis, Prosthesis Failure, Aortic Valve, Prosthesis Design, Risk Factors, Heart Valve Prosthesis Implantation, Aortic Valve Stenosis, Treatment Outcome, Reoperation, Patient Selection

Abstract

Bioprosthetic surgical aortic valve failure represents a significant clinical challenge that necessitates timely and effective intervention to restore valve function and ensure patient well-being. Use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as a feasible alternative to reoperation surgical aortic valve replacement (SAVR). By providing a less invasive option, this approach offers the opportunity to reduce the potential risks of a reoperation surgery. However, it is important to note that implementing ViV-TAVI requires careful preparation. This review outlines a thorough approach to ViV-TAVI, encompassing preprocedural planning, valve selection, implantation procedure, and its complications. With the availability of updated clinical data supporting long-term outcomes, this particular strategy is an excellent choice for the treatment of failed surgical aortic bioprostheses.

Medical Subject Headings

Humans; Heart Valve Prosthesis; Transcatheter Aortic Valve Replacement; Bioprosthesis; Prosthesis Failure; Aortic Valve; Prosthesis Design; Risk Factors; Heart Valve Prosthesis Implantation; Aortic Valve Stenosis; Treatment Outcome; Reoperation; Patient Selection

PubMed ID

40537958

ePublication

ePub ahead of print

Volume

106

Issue

2

First Page

1383

Last Page

1400

Find It @ Sladen

Share

COinS